Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    User Placeholder

    Hi,

    Logout

    India
    Business
    World
    Politics
    Sports
    Technology
    Entertainment
    Auto
    Lifestyle
    Inspirational
    Career
    Bengaluru
    Delhi
    Mumbai

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
    Home / News / India News / Three lakh healthcare workers will be inoculated on Day 1
    Next Article
    Three lakh healthcare workers will be inoculated on Day 1

    Three lakh healthcare workers will be inoculated on Day 1

    By Srijita Sen
    (PTI desk)
    Edited by Anamica Singh
    Jan 14, 2021
    01:08 pm

    What's the story

    Around three lakh healthcare workers will be inoculated at 2,934 sites across the country on day one of the nationwide COVID-19 vaccination drive which is set to begin from January 16, official sources said.

    Each vaccination session will cater to a maximum of 100 beneficiaries.

    The Union Health Ministry has advised states not to organize an "unreasonable number of vaccinations per site per day."

    Details

    Centre's advisory to states regarding vaccination sessions

    "States have been advised to organize vaccination sessions taking into account 10 percent reserve/wastage doses and an average of 100 vaccinations per session each day," the Ministry said on Wednesday.

    It also advised the states and Union Territories to increase the number of vaccination session sites that would be operational every day in a progressive manner as the vaccination process stabilizes and moves forward.

    You're
    14%
    through

    Choice

    Will recipients be given a choice between Covishield and COVAXIN?

    The government has hinted that recipients, for now, will not have the option to choose the vaccine.

    India has approved two vaccines for restricted emergency use - Oxford/Astrazeneca's Covishield, manufactured by Serum Institute of India, and COVAXIN, indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research.

    Getting vaccinated for COVID-19 will be voluntary, the Health Ministry has said.

    You're
    28%
    through

    Details

    Who are in line to receive the vaccination?

    According to the government, the shots will be offered first to an estimated one crore healthcare workers, and around two crore frontline workers, and then to persons above 50 years of age, followed by persons younger than 50 years of age with comorbidities.

    The cost of vaccination of healthcare and frontline workers will be borne by the central government, officials had said.

    You're
    42%
    through

    Vaccine procurement

    Procured doses allocated to states based on healthcare workers' database

    All 1.65 crore doses of COVID-19 vaccines, 1.1 crore of Covishield, and 55 lakh of COVAXIN, procured by the Centre have been allocated to all states and UTs in proportion to their healthcare workers' database.

    Most of the 1.1 crore Covishield doses from SII have been shipped to 60 consignee points across India from where they will be sent to smaller centers.

    You're
    57%
    through

    Sites

    First tranche of COVAXIN doses dispatched to 12 sites

    Of the 55 lakh doses of COVAXIN, the first tranche of 2.4 lakh doses has been dispatched to 12 sites- Ganavaram, Guwahati, Patna, Delhi, Kurukshetra, Bengaluru, Pune, Bhubaneswar, Jaipur, Chennai, Lucknow, and Hyderabad, official sources said.

    To recall, the vaccine will be given in two doses with a gap of 28 days between them, and its effectiveness will be seen only after 14 days.

    You're
    71%
    through

    Side effects

    Arrangements being made to deal with any vaccine-related side effects

    On the possible side-effects of the vaccine, AIIMS Director Dr. Randeep Guleria said that like other vaccines, some side effects in form of mild fever, pain at the site of injection, or body ache can be seen in some individuals.

    States have been asked to make arrangements to deal with any COVID-19 vaccine-related side effects as one of the measures toward safe vaccine delivery.

    You're
    85%
    through

    Information

    Can a person with an active COVID-19 infection be vaccinated?

    Dr. Randeep Guleria said a person with active and symptomatic COVID-19 infection may increase the risk of spreading the same to others at the vaccination site and thus infected individuals should defer vaccination for at least 14 days after the symptoms are resolved.

    Done!
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Latest
    Vaccine
    Coronavirus
    COVAXIN
    Covishield

    Latest

    Hyderabad fire: 8 children among 17 of family killed  Hyderabad
    Joe Biden diagnosed with 'aggressive' prostate cancer Joe Biden
    After YouTuber, UP businessman arrested for spying for Pakistan  Haryana
    OTT: When, where to watch 'Final Destination Bloodlines' Netflix

    Vaccine

    Coronavirus: Serum Institute ordered to halt recruitment for vaccine trial University of Oxford
    AstraZeneca resumes clinical trials for COVID-19 vaccine after UK nod Oxford University
    Not herd-immunity; vaccine critical for ending pandemic, says Bill Gates Microsoft
    One in seven volunteers for Sputnik V report side effects Russia News

    Coronavirus

    Pfizer study suggests vaccine works against coronavirus variant Pfizer
    Cutting COVID-19 infectious period could prevent millions of cases: Study Coronavirus Cases In India
    Coronavirus: Kejriwal makes seven-day institutional quarantine mandatory for UK returnees Arvind Kejriwal
    Bihar: 22 school students who tested COVID-positive now test negative Bihar

    COVAXIN

    Coronavirus, that killed over 500,000, isn't even nearing end: WHO South Korea
    India targets to launch first COVID-19 vaccine by August 15 Indian Council of Medical Research (ICMR)
    India's second COVID-19 vaccine cleared for human trials: Details here Drugs Controller General of India
    Following globally-accepted norms, says ICMR over August 15 vaccine target Vaccine

    Covishield

    India: Serum Institute's COVID-19 vaccine goes into Phase-2/3 trials Vaccine
    COVID-19 vaccine: Serum Institute to start final trials this week India
    Vaccine tracker: Covishield trials running smoothly; COVAXIN expected by February Serum Institute of India
    COVISHIELD vaccine could be realistic solution to COVID-19 pandemic: ICMR Indian Council of Medical Research (ICMR)
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2025